Business
ASX 200 drops 0.9% on Monday 11 January 2020
The S&P/ASX 200 Index (ASX: XJO) fell by almost 0.9% today to 6,697 points.
Here are the highlights from the ASX:
The Mesoblast share price went up 14% today after giving the market an update.
It announced today additional results from the landmark DREAM-HF randomised controlled phase 3 trial in 537 treated patients with chronic heart failure with reduced left ventricular ejection fraction (HFrEF) who received rexlemestrocel-L or control shame.
Mesoblast explained that a single dose of rexlemestrocel-L resulted in substantial and durable reductions in heart attacks, strokes and cardiac deaths.
The ASX 200 company said that existing therapies have only minimal or no benefit on these endpoints, these notable outcomes may signal a…
-
General22 hours agoGymnastics club in Berwick shuts down following child safety complaint
-
General16 hours agoAshes engulfed by fresh DRS controversy as TV umpire gives Jamie Smith out despite RTS ‘murmur’
-
General19 hours ago‘Mother’s Day’ solar storm squeezed Earth’s plasmasphere to one-fifth its size
-
General24 hours agoTwo dead after separate road accidents in regional New South Wales